Financial Statements Financial Statements 25 Other reserves All other Hedging Translation reserves reserve reserve Note a Total m m m m At 1 April 2011 7 58 110 175 Cash flow hedges: fair value losses in the year 2 2 reclassified and reported in the income statement during the year 3 3 Loss on revaluation of available-for-sale financial assets 1 1 Currency translation differences: net investment hedging gains in the year 3 3 Net exchange differences on consolidation 33 33 Items transferred to the income statement on disposal 11 11 At 31 March 2012 2 28 98 128 Cash flow hedges: fair value losses in the year 3 3 reclassified and reported in the income statement during the year 4 4 tax effect of the above movements 1 1 Loss on revaluation of available-for-sale financial assets 1 1 Currency translation differences: net investment hedging losses in the year 30 30 Net exchange differences on consolidation 56 56 Items transferred to the income statement on disposal 14 14 At 31 March 2013 2 40 97 139 a All other reserves include the merger reserve and the available-for-sale fair value reserve, both of which are non-distributable.
26 Share-based payments During the year to 31 March 2013, various equity-settled share-based payment arrangements existed, as set out below.
The grants made during the year and the prior year were as follows: Sharesave Plan Executive Deferred Group bonus Performance share option bonus share plan deferred Duration Type of arrangement share plan scheme plan benefit award in years Timing of grant Bi-annually Note a Annually as Annually Annually in applicable in June December in May Number of options shares granted 2 673 024 8 368 3 23 768 in year to 31 March 2013 5 13 442 Number of options shares granted 2 937 428 296 710 3 26 273 in year to 31 March 2012 5 7 823 Fair value per share for 2013 grant pence 619 697 3 198 5 208 Fair value per share for 2012 grant pence 542 555 3 126 5 141 Valuation basis Monte Carlo Binomial Monte Carlo Contractual BlackBlackLattice Scholes Scholes Contractual life 10 years 10 years 3 years 2 years 3 5 years 3 5 years Vesting conditions Note b Note c Note d Note f Note e Note e a The last grant under this scheme was made in June 2004. b For the year ended 31 March 2013, exercise of 2,673,024 shares is dependent 50% on adjusted diluted earnings per share and 50% on return on capital employed.
For the year ended 31 March 2012, exercise of 2,937,428 shares is dependent 50% on adjusted diluted earnings per share and 50% on return on capital employed.
c Exercise is dependent on earnings per share performance relative to inflation over a three-year period following grant.
Participants are not entitled to dividends prior to the exercise of options.
Tate & Lyle PLC Annual Report 2013 101 Financial Statements Notes to the Consolidated Financial Statements continued 26 Share-based payments continued d Executives have previously had the opportunity to defer up to 50% of their annual cash bonus after deduction of tax, national insurance or other social security payments and invest the amount deferred in the Companys shares.
Subject to the satisfaction of employment conditions and a performance target over the performance period as described in b above, participants received awards of matching shares based on the number of shares which could have been acquired from the gross bonus amount deferred by the participant.
During the performance period, dividends were paid on the deferred shares but not on matching shares.
This plan was suspended during the year ended 31 March 2009. e Options granted in the years to 31 March 2012 and 31 March 2013 were by invitation at a 20% discount to the market price.
Options are exercisable at the end of a three-year or five-year savings contract.
f The deferred benefit award will be exercisable at the end of a two-year period dependent on contractual obligations.
The Group recognised total expenses before tax of 13 million 2012 11 million related to equity-settled share-based payment transactions during the year.
Details of the movements for equity-settled share option schemes during the year to 31 March were as follows: 31 March 2013 31 March 2012 Weighted Weighted average average exercise exercise Shares price Shares price number pence number pence Outstanding at 1 April 11 270 273 16 11 211 368 32 Granted 2 718 602 8 3 268 234 6 Exercised 2 914 764 29 1 892 643 99 Lapsed 235 996 7 1 316 686 13 Outstanding at 31 March 10 838 115 10 11 270 273 16 The weighted average Tate & Lyle PLC share price at the date of exercise for share options exercised during the year was 654p 2012 647p.
At 31 March 2013 1,875,237 2012 862,865 of the outstanding options were exercisable at a weighted average exercise price of 29p 2012 154p.
A detailed breakdown of the range of exercise prices for options outstanding at 31 March is shown in the table below: Year to 31 March 2013 Year to 31 March 2012 Weighted Weighted Weighted Weighted average average average average Number remaining exercise Number remaining exercise outstanding contractual price outstanding contractual price at end of year life in months pence at end of year life in months pence At nil cost 10 573 265 49.1 10 788 721 47.3 0.01 to 1.99 2.00 to 3.99 167 358 14.6 326 403 619 22.1 333 4.00 to 7.99 97 492 37.6 547 77 933 37.4 494 Total 10 838 115 48.4 10 11 270 273 46.3 16 The fair value of grants is measured using the valuation technique that is considered to be the most appropriate to value each class of grant.
These include Binomial Lattice models, Black-Scholes calculations and Monte Carlo simulations.
These valuations take into account factors such as non-transferability, exercise restrictions and behavioural considerations.
Key assumptions are detailed below: Sharesave Performance Plan At 31 March 2013 share plan December Expected volatility n a 35% Expected life 3 years 3.3 5.3 years Risk-free rate 0.65 1.20% Expected dividend yield 4.0% 4.0% Forfeiture rate 0% 10% Correlation with comparators n a n a Volatility of comparators n a n a 1 Expectations of meeting performance criteria 80% n a Weighted average market price at date of grant pence 679 759 1 Relating to grants made during the year.
Tate & Lyle PLC Annual Report 2013 102
